I Holland to hold webinar on how to overcome tabletting challenges
Company will discuss common tabletting problems such as increasing output without capital expenditure, eliminating sticking and abrasion, minimising headwear and corrosion, all of which can be done through innovative means.
I Holland will host a webinar entitled ‘How to solve tabletting problems with innovative solutions’ on 29 September 2016, as part of its 70th anniversary celebrations.
Aimed for the tablet compression industry including pharmaceutical, nutraceutical, veterinary, confectionary and industrial sectors, the webinar seeks to provide helpful information and tips for those looking for new innovative solutions to everyday problems.
During the webinar, I Holland will discuss common tabletting problems such as increasing output without capital expenditure, eliminating sticking and abrasion, minimising headwear and corrosion, all of which can be done through innovative means. Tablet manufacturers are increasingly required to overcome and eliminate these problems with minimal investment to ensure a better quality end product providing direct cost savings and optimised productivity.
The first of this series of three webinars, entitled ‘Improve production efficiency from tablet design to tool maintenance and specification’, took place on 12 May 2016. Delivering structured advice to the tablet manufacturing industries, the webinar centred on how efficiency in solid dose manufacturing can be improved at the earliest stages of the tablet design process by utilising precise tooling specifications and can still be viewed on demand from I Holland’s website.
As 2016 signifies I Holland’s 70th anniversary in equipping its partners with affordable high quality tooling and technical support service and information, the webinars showcase the tabletting expert’s knowledge in choosing and optimising tablet design and tool material selection, features and configuration and tooling maintenance and life-cycle management.
“Webinars are a really easy and efficient way to explore common problems within the tablet manufacturing industry and share knowledge with our industry peers. We find that the interactive question and answer element of the session enable our prospective and existing partners to ask further questions and express common ideas and experiences,” says Alex Bunting, Marketing Manager, I Holland.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.